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edox metabolism of Leishmania parasite: Ideal target for drug
evelopment against leishmaniasis
. Shukla ∗, S. Patra, V. Dubey
Indian Institute of Technology Guwahati, Guwahati, AS, India
Background: Leishmaniasis is a tropical disease caused by
eishmania sp., a protozoan parasite of order kinetoplatida. The
arasite is transmitted to human via sandﬂy of genus Phlebota-
us. Due to absence of effective drug, the search for new drugs
ith more efﬁciency, least toxicity and parastic resistance still
emains as the current goal. Redox metabolism of Leishmania par-
site appears to be the most ideal target for drug development due
o involvement of several non-human homologous enzymes. One
uch unique enzyme is Trypanothione reductase (TryR), analogous
o Glutathione reductase in human host, which helps in removal of
eactive oxygen species and DNA synthesis. Thus inhibition of TryR
eads to death of Leishmania sp. due to oxidative stress.
Methods: Using integrated computational and biochemical
pproaches, we have identiﬁed few antitumor agents (doxorubicin
nd mitomycin C) as competitive inhibitors as well as subversive
ubstrates of TryR enzyme. These antitumor agents undergo a pro-
ess of cyclic conversion of quinone-hydroquinone in presence
f TryR and generate superoxide radical. This mechanism causes
eneration of oxidative stress via 1) loss of reducing equivalents
ADPH+H+, 2) generationof superoxide radical, and3) Inhibitionof
ryR. This subversive substrate mechanism was investigated using
arious methods like FT-IR analysis and enzyme activity. Further,
hese candidate drugswere screened for theirmode of action (inhi-
ition studies, ROS generation, apoptosis, cytotoxicity studies on
arasite and human cell lines, etc.)
Results:we found these antitumor agents tobe active as subver-
ive substrates and competitive inhibitors with Ki values 3.24 M
nd 12.65 M and IC50 values 11.52 M and 12.76 M for dox-
rubicin and mitomycin C respectively, which signiﬁes their high
fﬁciency as drug against Leishmania parasite. They also increase
OS level in parasite (estimated via Flow cytometry and ﬂuores-
ence studies) and lead to death via apoptosis assay.Conclusion:Doxorubicin andmitomycin cmay be developed as
nique and novel therapeutics for leishmaniasis.
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Multiple mitochondrial introgression events and heteroplasmy
inTrypanosomacruzi revealedbymaxicircleMLSTandnext gen-
eration sequencing
L. Messenger1,∗, M. Llewellyn1, T. Bhattacharyya1, O. Franzen2,
M. Lewis1, J.-D. Ramirez3, H. Carrasco4, B. Andresson2, M. Miles1
1 London School of Hygiene and Tropical Medicine, London, United
Kingdom
2 Karolinska Institutet, Stockholm, Sweden
3 Universidad de los Andes, Bogota, Colombia
4 Universidad Central de Venezuela, Caracas, Venezuela
Background: Mitochondrial DNA is a valuable taxonomic
marker due to its relatively fast rate of evolution. In Trypanosoma
cruzi, the causative agent of Chagas disease, the mitochondrial
genome has a unique structural organization consisting of 20-50
maxicircles (∼20kb) and thousands of minicircles (0.5-10kb). T.
cruzi is an early diverging protist displaying remarkable genetic
heterogeneity and is recognized as a complex of six discrete
typing units (DTUs). The majority of infected humans are asymp-
tomatic for life while 30-35% develop fatal cardiac and/or digestive
syndromes. However, the relationship between speciﬁc clinical
outcomes and T. cruzi genotype remains elusive. The availability
ofwhole genome sequences has driven advances in high resolution
genotyping techniques and re-invigorated interest in exploring the
cryptic genetic diversity present within the various DTUs.
Methods: To describe intra-DTU diversity, we developed a
highly resolutive maxicircle multilocus sequence typing (mtMLST)
scheme, which was evaluated in comparison with current nuclear
typing tools using isolates belonging to the oldest and most widely
occurring lineage TcI. In parallel,we exploited readdepthdata, gen-
erated by Illumina sequencing of the maxicircle genome from the
TcI reference strain to investigate the existence of mitochondrial
heteroplasmy (heterogeneous mitochondrial genomes in an indi-
vidual cell) in T. cruzi and resolve its potential role as a source of
genotyping error.
Results: Comparison of nuclear and mitochondrial data uncov-
ered multiple novel mitochondrial introgression events among
different geographical populations from Bolivia, Venezuela and
Colombia aswell as betweenmajorT. cruzi DTUs. Illumina sequenc-
ing data from the TcI genome strain revealed multiple different
mitochondrial genomes within an individual parasite (hetero-
plasmy) thatwere, however, not sufﬁciently divergent to represent
a major source of typing error.
Conclusion: mtMLST provides a powerful approach to geno-
typing at the sub-DTU level. This strategy will facilitate attempts
to resolve phenotypic variation in T. cruzi and to address epi-
demiologically importanthypotheses in conjunctionwith intensive
spatio-temporal sampling. The observations of both general and
speciﬁc incidences of nuclear-mitochondrial phylogenetic incon-
gruence indicate that genetic recombination is geographically
widespread and continues to inﬂuence the natural population
structure of TcI, a conclusion which challenges the traditional
paradigm of clonality in T. cruzi.
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